First participant implanted in Paradromics' FDA-approved Connect-One study

Paradromics/Connexus BCI

University of Michigan surgeons completed the first permanent brain-computer interface implant in Paradromics' FDA-approved Connect-One early feasibility study. The Connexus device records neural signals through a high-density microelectrode array, transmitting wirelessly to an external receiver via a chest transceiver, with the six-year study testing long-term speech restoration and computer control.

• First Connexus BCI implant completed at University of Michigan Health in FDA-approved early feasibility study.
• High-density microelectrode array wired to chest transceiver transmits neural signals wirelessly through the skin.
• Six-year study will enrol additional patients at UC Davis and Massachusetts General Hospital to test speech and computer control restoration.